These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20142257)

  • 1. Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).
    Patrick-Miller L; Bradbury AR; Terry MB
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):624-7. PubMed ID: 20142257
    [No Abstract]   [Full Text] [Related]  

  • 2. Abstracts of the 33rd Annual Meeting, American Society of Preventive Oncology, Tampa, Florida, March 8-10, 2009.
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):688-93. PubMed ID: 19208666
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of genetic testing for risk of Alzheimer's disease.
    Kane RA; Kane RL
    N Engl J Med; 2009 Jul; 361(3):298-9. PubMed ID: 19605835
    [No Abstract]   [Full Text] [Related]  

  • 4. Disclosure/disruption: considering why not to disclose genetic information after death.
    Galvin K; Clayman ML
    Am J Bioeth; 2012; 12(10):14-6. PubMed ID: 22974021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Social and family considerations in genetic counselling].
    Svendsen MN; Koch L
    Ugeskr Laeger; 2006 Jun; 168(24):2348-50. PubMed ID: 16822418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disclosing individual genetic research results to deceased participants' relatives by means of a qualified disclosure policy.
    Bredenoord AL; van Delden JJ
    Am J Bioeth; 2012; 12(10):10-2. PubMed ID: 22974019
    [No Abstract]   [Full Text] [Related]  

  • 7. Disclosure of the genetic risk of Alzheimer's disease.
    Gordon SC; Landa D
    N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713
    [No Abstract]   [Full Text] [Related]  

  • 8. Blurring boundaries.
    Nijsingh N
    Am J Bioeth; 2012; 12(10):26-7. PubMed ID: 22974027
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward Achieving Health Equity - ASPO's 2022 Annual Meeting March 13-15, 2022 Marriott University Park, Tucson, Arizona.
    Gomez SL; Patierno SR
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2140. PubMed ID: 34728533
    [No Abstract]   [Full Text] [Related]  

  • 10. Rethinking clinical risk for DNA sequencing.
    May T
    Am J Bioeth; 2012; 12(10):24-6. PubMed ID: 22974026
    [No Abstract]   [Full Text] [Related]  

  • 11. Disclosing results to genomic research participants: differences that matter.
    Blasimme A; Soulier A; Julia S; Leonard S; Cambon-Thomsen A
    Am J Bioeth; 2012; 12(10):20-2. PubMed ID: 22974024
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinically significant? Depends on whom you ask.
    Johnson LM; Church CL; Walsh MF; Baker JN
    Am J Bioeth; 2012; 12(10):18-20. PubMed ID: 22974023
    [No Abstract]   [Full Text] [Related]  

  • 13. Risks to relatives in genomic research: a duty to warn?
    Bombard Y; Offit K; Robson ME
    Am J Bioeth; 2012; 12(10):12-4. PubMed ID: 22974020
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficence, clinical urgency, and the return of individual research results to relatives.
    Fullerton SM; Trinidad SB; Jarvik GP; Burke W
    Am J Bioeth; 2012; 12(10):9-10. PubMed ID: 22974018
    [No Abstract]   [Full Text] [Related]  

  • 15. The ever-evolving concept of clinical significance and the potential for sins of omission in genetic research.
    Costain G; Bassett AS
    Am J Bioeth; 2012; 12(10):22-4. PubMed ID: 22974025
    [No Abstract]   [Full Text] [Related]  

  • 16. Disclosing decedents' research results to relatives violates the HIPAA Privacy Rule.
    Rothstein MA
    Am J Bioeth; 2012; 12(10):16-7. PubMed ID: 22974022
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility and limitations of genetic testing and information.
    Bradley AN
    Nurs Stand; 2005 Oct 12-18; 20(5):52-5. PubMed ID: 16255487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing and health insurance practices: an industry perspective.
    Volpe LC
    Genet Test; 1998; 2(1):9-12. PubMed ID: 10464592
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic testing: is there a right not to know?
    Rhodes R
    MCN Am J Matern Child Nurs; 2006; 31(3):145. PubMed ID: 16679953
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic testing: is there a right not to know?
    Zinberg RE
    MCN Am J Matern Child Nurs; 2006; 31(3):144. PubMed ID: 16679952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.